Trellus Management Company, LLC Codiak Bio Sciences, Inc. Transaction History

Trellus Management Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$0.82 - $3.19 $11,434 - $44,484	-13,945 Reduced 17.76%	64,582 $51,000
Q2 2022 Jul 13, 2022	SELL	$2.24 - $6.96 $12,333 - $38,321	-5,506 Reduced 6.55%	78,527 $226,000
Q4 2021 Jan 31, 2022	BUY	$10.0 - $16.78 $210,630 - $353,437	21,063 Added 33.45%	84,033 $936,000
Q3 2021 Oct 26, 2021	BUY	$15.58 - $22.88 $392,148 - $575,889	25,170 Added 66.59%	62,970 $1.03 Million
Q2 2021 Jul 30, 2021	SELL	$11.72 - $26.81 $84,384 - $193,032	-7,200 Reduced 16.0%	37,800 $700,000

Q1 2021 May 03, 2021	BUY	$13.49 - $31.53 $607,050 - $1.42 Million	45,000 New	45,000 $679,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.